[spacer image]
BD
[spacer image]
About Us
[spacer image]
Products
[spacer image]
News
[spacer image]
Events
[spacer image]
Contact Us
[spacer image]
GeneOhm Home
[spacer image]
[spacer image]

News
Email Page Print
[spacer image]

November 19, 2009
BD Completes Acquisition of HandyLab, Inc.
October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc.
August 06, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio
August 05, 2009
APIC Announces Launch of Online Education Center for Instant Access to Comprehensive Infection Prevention
May 18, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays

March 25, 2009
BD Announces Health Canada Licensing of Novel Molecular Assay for the Detection of Vancomycin Resistance Genes
January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections

December 17, 2008
BD Selected to Participate in Premier QUEST Nationwide Hospital Collaborative to Reduce Healthcare-Associated Infections
November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene

July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections

June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec
April 07, 2008
Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens
December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent
November 05, 2007
BD Sponsors New Tool to Combat MRSA Infections in Hospitals
October 04, 2007
BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
March 12, 2007
Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF)
March 12, 2007
Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF)
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]
Site Map
Privacy | Terms & Conditions | Permission Request | Trademarks
BD Worldwide
BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2009 BD